← FDA DRUG APPROVALS

FDA ANDA · ANDA215940

ADAPALENE

Sponsor: SUN PHARMA CANADA

APPLICATION
ANDA215940
TYPE
ANDA
ORIGINAL APPROVAL
2022-01-14
LATEST ACTION
2023-07-06
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Over-the-counter

Products

ADAPALENEOver-the-counter
ADAPALENE 0.1% · GEL · TOPICAL

Approval history

2023-07-06Manufacturing (CMC) · Supplement 1 · unknownAP
2022-01-14UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →